TRESIBA

Google image searchProduct monograph

Active ingredient

insulin degludec, 100 UNIT/ML

DIN: 02467860

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: PENFILL (CARTRIDGE)

Schedule: Schedule D

Company: NOVO NORDISK CANADA INC

Date: 30-JAN-2023

ATC:

• A10 — DRUGS USED IN DIABETES (ATC, ATC/DDD, )
• A10A — INSULINS AND ANALOGUES (ATC, ATC/DDD)
• A10AE — Insulins and analogues for injection, long-acting (ATC, ATC/DDD)
• A10AE06 — INSULIN DEGLUDEC (ATC/DDD)

Reference brand drug: Tresiba

External Links for Tresiba

Search on Google

• Tresiba side effects
• Tresiba dosage
• insulin degludec side effects
• insulin degludec dosage

Novo Nordisk Canada Inc

Go to Novo Nordisk website to see drug product details. Sometimes you can find tresiba photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.